Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr408 Inhibitors

Olr408 inhibitors represent a fascinating chemical class that interacts specifically with the Olr408 receptor, a member of the olfactory receptor (OR) family. Olfactory receptors are G-protein-coupled receptors (GPCRs) expressed in the olfactory epithelium, playing a critical role in the detection of odor molecules and the initiation of olfactory signal transduction. Olr408 inhibitors are designed to selectively bind to this particular receptor, modulating its activity by either preventing the binding of its natural ligands or altering its conformation to reduce its signal transduction efficacy. These inhibitors are typically small molecules, synthesized to interact with specific amino acid residues within the binding pocket of the Olr408 receptor, thus interfering with the receptor's ability to convey signals effectively.

The study of Olr408 inhibitors has significant implications for understanding the molecular mechanisms underlying olfaction. By blocking or modulating the Olr408 receptor, researchers can investigate the receptor's role in olfactory processes, offering insights into how specific odors are detected and processed at the molecular level. Additionally, the specificity of these inhibitors for the Olr408 receptor allows for the dissection of signaling pathways within olfactory neurons, further elucidating the complex interactions between different olfactory receptors and their associated signaling molecules. This research can lead to a deeper comprehension of olfactory coding and the structural-functional relationships inherent in GPCRs, contributing to broader studies on sensory perception and signal transduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Azelnidipine

123524-52-7sc-252395
10 mg
$86.00
(1)

Calcium channel blocker, can indirectly affect GPCR signaling by altering calcium ion dynamics, potentially impacting Olr408.

Canagliflozin

842133-18-0sc-364454
sc-364454A
5 mg
50 mg
$312.00
$416.00
2
(0)

SGLT2 inhibitor, might influence GPCR signaling indirectly through glucose metabolism modulation, impacting Olr408.

Dapagliflozin

461432-26-8sc-364481
sc-364481A
sc-364481B
5 mg
50 mg
1 g
$117.00
$428.00
$1051.00
6
(1)

SGLT2 inhibitor, could alter GPCR signaling indirectly via effects on renal glucose reabsorption, impacting Olr408.

Empagliflozin

864070-44-0sc-482194
sc-482194A
sc-482194B
sc-482194C
1 g
5 g
10 g
100 g
$165.00
$322.00
$407.00
$1221.00
5
(0)

SGLT2 inhibitor, may affect GPCR signaling pathways indirectly through glucose homeostasis modulation, impacting Olr408.

Ivabradine hydrochloride

148849-67-6sc-507513
10 mg
$120.00
(0)

If channel inhibitor, might influence GPCR signaling indirectly through cardiac electrophysiological effects, impacting Olr408.

Mirabegron

223673-61-8sc-211912
500 mg
$475.00
5
(3)

Beta-3 adrenergic agonist, may modulate GPCR signaling pathways, potentially affecting Olr408.

Repaglinide

135062-02-1sc-219959
sc-219959A
sc-219959B
100 mg
250 mg
1 g
$219.00
$422.00
$1358.00
3
(0)

Meglitinide, might modulate GPCR signaling indirectly through insulin secretion enhancement, impacting Olr408.

Rivaroxaban

366789-02-8sc-208311
2 mg
$158.00
18
(1)

Anticoagulant, could influence GPCR signaling indirectly through effects on coagulation pathways, impacting Olr408.

Telmisartan

144701-48-4sc-204907
sc-204907A
50 mg
100 mg
$72.00
$94.00
8
(1)

Angiotensin II receptor blocker, may indirectly modulate GPCR signaling, potentially affecting Olr408.